Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03960619 · ClinicalTrials.gov registry record · NA
In Person and Mobile Health Coping Skills Training for Improving Symptom Management and Daily Steps in Hematopoietic Stem Cell Transplant Patients
A NA study of Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma), sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03960619: Completed NA study of Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma), sponsored by Duke University.
NCT03960619 is a NA study of Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma) that has completed, run by Duke University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03960619, a NA study of Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma), has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the feasibility, acceptability, and efficacy of a novel mHealth behavioral intervention to enable HCT patients to effectively cope with symptoms to improve their ability to engage in physical activity that can improve physical disability. Our interdisciplinary team (psychiatry, hematology/oncology, occupational therapy) proposes a single arm pilot trial (N=20) to test a hybrid in-person and mHealth (video-conferencing, symptoms/activity monitoring, personalized feedback via text) HCT Coping Skills Training for Symptom Management and Daily Steps (CST Step-Up) intervention. CST Step-Up will provide patients with coping skills training and activity coaching sessions to enhance their ability to cope with symptoms that interfere with activity.
Primary Outcome
Accrual will be indicated by meeting the recruitment goal
Conditions Studied
Interventions
- BEHAVIORAL coping skills training
Study Locations (1)
North Carolina
- Duke university health system - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2019-11-22 |
| Phase | NA |
What the finished NCT03960619 record still lists
NCT03960619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma) appearing as the primary indexed condition, and to 1 intervention - of which coping skills training is the first listed.
NCT03960619 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03960619 about?
NCT03960619 is a clinical study titled "In Person and Mobile Health Coping Skills Training for Improving Symptom Management and Daily Steps in Hematopoietic Stem Cell Transplant Patients". The purpose of the study is to assess the feasibility, acceptability, and efficacy of a novel mHealth behavioral intervention to enable HCT patients to effectively cope with symptoms to improve their ability to engage in physical activity that can improve physical disability. Our interdisciplinary t...
What is the current status of trial NCT03960619?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-07-16. Estimated completion is 2019-11-22.
What conditions does trial NCT03960619 study?
This clinical trial studies the following conditions: Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma).
What interventions are being tested in trial NCT03960619?
The interventions under investigation include: coping skills training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03960619?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03960619 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03960619's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI